

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.31287420 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.93945721 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.45126196 |
| 4 | DNA deamination (GO:0045006) | 5.28701298 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.23208912 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.23208912 |
| 7 | mannose metabolic process (GO:0006013) | 5.05929839 |
| 8 | viral transcription (GO:0019083) | 5.00957939 |
| 9 | B cell receptor signaling pathway (GO:0050853) | 4.95874208 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 4.92011847 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.91971907 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.77033704 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.74569200 |
| 14 | translational termination (GO:0006415) | 4.72832953 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.47313562 |
| 16 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.42074839 |
| 17 | cotranslational protein targeting to membrane (GO:0006613) | 4.28376031 |
| 18 | protein targeting to ER (GO:0045047) | 4.27605135 |
| 19 | regulation of B cell differentiation (GO:0045577) | 4.26624972 |
| 20 | translational elongation (GO:0006414) | 4.24508992 |
| 21 | protein localization to endoplasmic reticulum (GO:0070972) | 4.07651842 |
| 22 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.06686297 |
| 23 | response to peptidoglycan (GO:0032494) | 4.04358952 |
| 24 | detection of bacterium (GO:0016045) | 4.00853246 |
| 25 | ribosomal small subunit biogenesis (GO:0042274) | 3.98996562 |
| 26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.94706121 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 3.94706121 |
| 28 | positive regulation by symbiont of host defense response (GO:0052509) | 3.94706121 |
| 29 | modulation by symbiont of host defense response (GO:0052031) | 3.94706121 |
| 30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.94706121 |
| 31 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.94706121 |
| 32 | valine metabolic process (GO:0006573) | 3.90901289 |
| 33 | detection of other organism (GO:0098543) | 3.90027877 |
| 34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.88561471 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.82418518 |
| 36 | thymic T cell selection (GO:0045061) | 3.71037767 |
| 37 | viral life cycle (GO:0019058) | 3.68263982 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.66039527 |
| 39 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.64112569 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.63876899 |
| 41 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.63432258 |
| 42 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.60912601 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.59311209 |
| 44 | cellular protein complex disassembly (GO:0043624) | 3.58784004 |
| 45 | T cell homeostasis (GO:0043029) | 3.54427239 |
| 46 | leukocyte aggregation (GO:0070486) | 3.53385466 |
| 47 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.49651600 |
| 48 | lymph node development (GO:0048535) | 3.47790539 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42906534 |
| 50 | response to interleukin-15 (GO:0070672) | 3.39406786 |
| 51 | mature B cell differentiation involved in immune response (GO:0002313) | 3.36620344 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 3.32988835 |
| 53 | germinal center formation (GO:0002467) | 3.31195439 |
| 54 | cellular response to interferon-beta (GO:0035458) | 3.25032604 |
| 55 | T cell selection (GO:0045058) | 3.24430117 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.21743163 |
| 57 | protein complex disassembly (GO:0043241) | 3.20840598 |
| 58 | detection of external biotic stimulus (GO:0098581) | 3.18792985 |
| 59 | regulation of ARF GTPase activity (GO:0032312) | 3.15869976 |
| 60 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.10723895 |
| 61 | regulation of regulatory T cell differentiation (GO:0045589) | 3.09214455 |
| 62 | regulation of leukocyte degranulation (GO:0043300) | 3.08546420 |
| 63 | translational initiation (GO:0006413) | 3.08438810 |
| 64 | megakaryocyte development (GO:0035855) | 3.07851188 |
| 65 | mature B cell differentiation (GO:0002335) | 3.07693949 |
| 66 | purine-containing compound salvage (GO:0043101) | 3.07096442 |
| 67 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05818963 |
| 68 | negative T cell selection (GO:0043383) | 3.04930251 |
| 69 | leukocyte homeostasis (GO:0001776) | 3.03259046 |
| 70 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.02277401 |
| 71 | Peyers patch development (GO:0048541) | 3.02277401 |
| 72 | response to interferon-beta (GO:0035456) | 3.01989043 |
| 73 | negative regulation of interleukin-12 production (GO:0032695) | 3.01679563 |
| 74 | positive regulation of granulocyte differentiation (GO:0030854) | 3.00956844 |
| 75 | macromolecular complex disassembly (GO:0032984) | 2.98657607 |
| 76 | lymphocyte homeostasis (GO:0002260) | 2.97248215 |
| 77 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.93195864 |
| 78 | positive T cell selection (GO:0043368) | 2.90489764 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.90096445 |
| 80 | negative regulation of phagocytosis (GO:0050765) | 2.89712544 |
| 81 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.85309077 |
| 82 | negative regulation of cell killing (GO:0031342) | 2.85309077 |
| 83 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83782404 |
| 84 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83314488 |
| 85 | negative regulation of humoral immune response (GO:0002921) | 2.82773976 |
| 86 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.82691644 |
| 87 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.81901699 |
| 88 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.81544332 |
| 89 | response to protozoan (GO:0001562) | 2.81267487 |
| 90 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81188980 |
| 91 | mast cell activation (GO:0045576) | 2.80532648 |
| 92 | protein targeting to membrane (GO:0006612) | 2.80475111 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80366198 |
| 94 | detection of biotic stimulus (GO:0009595) | 2.79451318 |
| 95 | tolerance induction (GO:0002507) | 2.79207897 |
| 96 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.79135926 |
| 97 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.78320754 |
| 98 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.77713509 |
| 99 | defense response to protozoan (GO:0042832) | 2.77129185 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76814304 |
| 101 | definitive hemopoiesis (GO:0060216) | 2.74920673 |
| 102 | cellular response to interleukin-4 (GO:0071353) | 2.74526456 |
| 103 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.74511447 |
| 104 | positive thymic T cell selection (GO:0045059) | 2.73027039 |
| 105 | NIK/NF-kappaB signaling (GO:0038061) | 2.70391079 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.69491944 |
| 107 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.69339177 |
| 108 | modulation by virus of host process (GO:0019054) | 2.67311524 |
| 109 | cellular response to interleukin-15 (GO:0071350) | 2.66327156 |
| 110 | mRNA catabolic process (GO:0006402) | 2.65239251 |
| 111 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.63775900 |
| 112 | regulation of erythrocyte differentiation (GO:0045646) | 2.63222081 |
| 113 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.63026399 |
| 114 | platelet dense granule organization (GO:0060155) | 2.62279770 |
| 115 | maturation of SSU-rRNA (GO:0030490) | 2.61664859 |
| 116 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.61443485 |
| 117 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61241391 |
| 118 | modulation by symbiont of host cellular process (GO:0044068) | 2.61054276 |
| 119 | activation of JUN kinase activity (GO:0007257) | 2.60095583 |
| 120 | lymphoid progenitor cell differentiation (GO:0002320) | 2.59411621 |
| 121 | necroptotic process (GO:0070266) | 2.58457843 |
| 122 | response to type I interferon (GO:0034340) | 2.58220720 |
| 123 | pentose-phosphate shunt (GO:0006098) | 2.57310898 |
| 124 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57209440 |
| 125 | T cell migration (GO:0072678) | 2.57112905 |
| 126 | negative regulation of innate immune response (GO:0045824) | 2.57103421 |
| 127 | signal complex assembly (GO:0007172) | 2.56982434 |
| 128 | regulation of granulocyte differentiation (GO:0030852) | 2.56938040 |
| 129 | purine nucleotide salvage (GO:0032261) | 2.56321775 |
| 130 | negative regulation of granulocyte differentiation (GO:0030853) | 2.55181003 |
| 131 | myeloid cell activation involved in immune response (GO:0002275) | 2.55145946 |
| 132 | detection of molecule of bacterial origin (GO:0032490) | 2.54287742 |
| 133 | regulation of regulated secretory pathway (GO:1903305) | 2.53759281 |
| 134 | cellular extravasation (GO:0045123) | 2.53201752 |
| 135 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.52601535 |
| 136 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.52142127 |
| 137 | response to host immune response (GO:0052572) | 2.52142127 |
| 138 | positive regulation of protein deacetylation (GO:0090312) | 2.51974251 |
| 139 | response to laminar fluid shear stress (GO:0034616) | 2.50970421 |
| 140 | regulation of antigen processing and presentation (GO:0002577) | 2.50559393 |
| 141 | positive regulation of Rap GTPase activity (GO:0032854) | 2.50049683 |
| 142 | negative regulation of interleukin-6 production (GO:0032715) | 2.49903915 |
| 143 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.48690799 |
| 144 | response to host (GO:0075136) | 2.48690799 |
| 145 | response to host defenses (GO:0052200) | 2.48690799 |
| 146 | cellular hyperosmotic response (GO:0071474) | 2.48443595 |
| 147 | immunoglobulin mediated immune response (GO:0016064) | 2.48187762 |
| 148 | type I interferon signaling pathway (GO:0060337) | 2.47631063 |
| 149 | cellular response to type I interferon (GO:0071357) | 2.47631063 |
| 150 | embryonic hemopoiesis (GO:0035162) | 2.46686204 |
| 151 | B cell activation (GO:0042113) | 2.46607209 |
| 152 | cellular response to virus (GO:0098586) | 2.46201582 |
| 153 | respiratory burst (GO:0045730) | 2.45776672 |
| 154 | regulation of T cell tolerance induction (GO:0002664) | 2.45592303 |
| 155 | myeloid dendritic cell differentiation (GO:0043011) | 2.44879632 |
| 156 | negative regulation of T cell mediated immunity (GO:0002710) | 2.44688435 |
| 157 | positive regulation of DNA biosynthetic process (GO:2000573) | 2.44215227 |
| 158 | positive regulation of histone deacetylation (GO:0031065) | 2.43838886 |
| 159 | RNA catabolic process (GO:0006401) | 2.43631180 |
| 160 | tricarboxylic acid metabolic process (GO:0072350) | 2.43223001 |
| 161 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.43197586 |
| 162 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.42964862 |
| 163 | mast cell degranulation (GO:0043303) | 2.42206620 |
| 164 | mast cell activation involved in immune response (GO:0002279) | 2.42206620 |
| 165 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.40533305 |
| 166 | negative thymic T cell selection (GO:0045060) | 2.37993085 |
| 167 | heme biosynthetic process (GO:0006783) | 2.37338270 |
| 168 | negative regulation of B cell apoptotic process (GO:0002903) | 2.36977866 |
| 169 | B cell differentiation (GO:0030183) | 2.35095155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.70196129 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.66910278 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.39662009 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.10228947 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.94233441 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.90785817 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.88823559 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.82472039 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82373314 |
| 10 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.75493626 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.72332330 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68578082 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.64511143 |
| 14 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.54522553 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42645155 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35899323 |
| 17 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.33542662 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.18068178 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06864417 |
| 20 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.98513064 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.97966880 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.96872227 |
| 23 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95603126 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.95293119 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.95272832 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.94714008 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.94705160 |
| 28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.93948850 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.92571106 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.91572360 |
| 31 | P68_20966046_ChIP-Seq_HELA_Human | 1.89340827 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84189273 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83037281 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.82511886 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82198341 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81987342 |
| 37 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.81018411 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.80064000 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79496006 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.79025498 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.73193048 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.72673595 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71770988 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71402601 |
| 45 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.71381259 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.71138165 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.69175970 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.68655977 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67487256 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66224967 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65092688 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.64288021 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.62075948 |
| 54 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.60558326 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60017918 |
| 56 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60003103 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.59745475 |
| 58 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.58577550 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58356575 |
| 60 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.58176971 |
| 61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.58070034 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.57139555 |
| 63 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57069394 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55058245 |
| 65 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54220920 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53817879 |
| 67 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.53513728 |
| 68 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53381832 |
| 69 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52727170 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.52227209 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51986992 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.49623953 |
| 73 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47824062 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.47581452 |
| 75 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.47219697 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.45750848 |
| 77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44960092 |
| 78 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.41857887 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41209820 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.39422918 |
| 81 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.39038178 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38419907 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36010711 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35561367 |
| 85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.33532659 |
| 86 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.33439249 |
| 87 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32008659 |
| 88 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.31940735 |
| 89 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.31380588 |
| 90 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30741581 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.29453351 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28497247 |
| 93 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28343846 |
| 94 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27843677 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27738711 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.27241170 |
| 97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26708190 |
| 98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26336167 |
| 99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25991394 |
| 100 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.25929250 |
| 101 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.25901312 |
| 102 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.25720622 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24907074 |
| 104 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.24808836 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23778667 |
| 106 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23083385 |
| 107 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22334093 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21562911 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21093599 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20956912 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20871153 |
| 112 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20790050 |
| 113 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20233663 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19801757 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19608989 |
| 116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18992572 |
| 117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18699830 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18519134 |
| 119 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.18062185 |
| 120 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17704825 |
| 121 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17695755 |
| 122 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.16733938 |
| 123 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14554366 |
| 124 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14179165 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13132789 |
| 126 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12505440 |
| 127 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11576940 |
| 128 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.11542860 |
| 129 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11263275 |
| 130 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11048101 |
| 131 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.11013579 |
| 132 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.09501622 |
| 133 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08991393 |
| 134 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08407784 |
| 135 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.08166815 |
| 136 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07191307 |
| 137 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06939243 |
| 138 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.05052503 |
| 139 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04480807 |
| 140 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02506676 |
| 141 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02189109 |
| 142 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02068897 |
| 143 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01675367 |
| 144 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.01247270 |
| 145 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00355763 |
| 146 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00063964 |
| 147 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00019138 |
| 148 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.99240879 |
| 149 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98683177 |
| 150 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.98458325 |
| 151 | P300_27268052_Chip-Seq_Bcells_Human | 0.96121419 |
| 152 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95467227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.83292639 |
| 2 | MP0000685_abnormal_immune_system | 3.73052449 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.68794632 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.11228031 |
| 5 | MP0001800_abnormal_humoral_immune | 3.09564369 |
| 6 | MP0005387_immune_system_phenotype | 2.84570440 |
| 7 | MP0001790_abnormal_immune_system | 2.84570440 |
| 8 | MP0001873_stomach_inflammation | 2.79384967 |
| 9 | MP0005671_abnormal_response_to | 2.61496366 |
| 10 | MP0002452_abnormal_antigen_presenting | 2.42042849 |
| 11 | MP0002398_abnormal_bone_marrow | 2.41499682 |
| 12 | MP0009278_abnormal_bone_marrow | 2.34346248 |
| 13 | MP0000689_abnormal_spleen_morphology | 2.31285584 |
| 14 | MP0006054_spinal_hemorrhage | 2.30797201 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.27048668 |
| 16 | MP0002723_abnormal_immune_serum | 2.25500582 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.22617559 |
| 18 | MP0001819_abnormal_immune_cell | 2.19420353 |
| 19 | MP0008260_abnormal_autophagy | 2.19056511 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.14832351 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.08332966 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.07154829 |
| 23 | MP0005365_abnormal_bile_salt | 2.05999718 |
| 24 | MP0000716_abnormal_immune_system | 2.05866893 |
| 25 | MP0009785_altered_susceptibility_to | 2.05079292 |
| 26 | MP0005025_abnormal_response_to | 2.01840794 |
| 27 | MP0002722_abnormal_immune_system | 2.01171518 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.97242273 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.93673702 |
| 30 | MP0006082_CNS_inflammation | 1.87327236 |
| 31 | MP0002429_abnormal_blood_cell | 1.86775956 |
| 32 | MP0000490_abnormal_crypts_of | 1.84177606 |
| 33 | MP0002419_abnormal_innate_immunity | 1.76578633 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.73179820 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.72959971 |
| 36 | MP0005220_abnormal_exocrine_pancreas | 1.68310985 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.66116272 |
| 38 | MP0003436_decreased_susceptibility_to | 1.65465562 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.58014677 |
| 40 | MP0003866_abnormal_defecation | 1.57843545 |
| 41 | MP0001853_heart_inflammation | 1.56574396 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.56003932 |
| 43 | MP0001849_ear_inflammation | 1.55372629 |
| 44 | MP0000858_altered_metastatic_potential | 1.55255482 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.54875414 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.54875414 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.51608237 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.50589736 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.49896403 |
| 50 | MP0002405_respiratory_system_inflammati | 1.48240851 |
| 51 | MP0004381_abnormal_hair_follicle | 1.46467377 |
| 52 | MP0002139_abnormal_hepatobiliary_system | 1.44552192 |
| 53 | MP0003693_abnormal_embryo_hatching | 1.43488767 |
| 54 | MP0005083_abnormal_biliary_tract | 1.42300688 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.41457754 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.35247692 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.34128422 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.27452275 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.27303499 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.27015706 |
| 61 | MP0002933_joint_inflammation | 1.25279619 |
| 62 | MP0002006_tumorigenesis | 1.22532431 |
| 63 | MP0008469_abnormal_protein_level | 1.20927113 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.20139733 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.19987002 |
| 66 | MP0002095_abnormal_skin_pigmentation | 1.17427990 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.16456590 |
| 68 | MP0005409_darkened_coat_color | 1.16376911 |
| 69 | MP0003303_peritoneal_inflammation | 1.14601814 |
| 70 | MP0003091_abnormal_cell_migration | 1.11257131 |
| 71 | MP0001764_abnormal_homeostasis | 1.10952877 |
| 72 | MP0004947_skin_inflammation | 1.05340719 |
| 73 | MP0000609_abnormal_liver_physiology | 1.03950181 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.03676485 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 1.03653468 |
| 76 | MP0005360_urolithiasis | 1.03397272 |
| 77 | MP0003868_abnormal_feces_composition | 1.02758940 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00921016 |
| 79 | MP0004858_abnormal_nervous_system | 1.00227819 |
| 80 | MP0003075_altered_response_to | 0.99512927 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 0.99488570 |
| 82 | MP0008007_abnormal_cellular_replicative | 0.99419931 |
| 83 | MP0005375_adipose_tissue_phenotype | 0.99376303 |
| 84 | MP0003806_abnormal_nucleotide_metabolis | 0.99095123 |
| 85 | MP0003724_increased_susceptibility_to | 0.99079198 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.98880711 |
| 87 | MP0002928_abnormal_bile_duct | 0.98054130 |
| 88 | MP0005058_abnormal_lysosome_morphology | 0.98008601 |
| 89 | MP0005390_skeleton_phenotype | 0.97929768 |
| 90 | MP0004147_increased_porphyrin_level | 0.95595044 |
| 91 | MP0001958_emphysema | 0.95508555 |
| 92 | MP0002132_abnormal_respiratory_system | 0.94503514 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.94326235 |
| 94 | MP0009379_abnormal_foot_pigmentation | 0.93877042 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.93756292 |
| 96 | MP0004510_myositis | 0.91582922 |
| 97 | MP0003252_abnormal_bile_duct | 0.90576695 |
| 98 | MP0009840_abnormal_foam_cell | 0.90270885 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.90160353 |
| 100 | MP0000604_amyloidosis | 0.89914939 |
| 101 | MP0003828_pulmonary_edema | 0.89790189 |
| 102 | MP0001851_eye_inflammation | 0.89498480 |
| 103 | MP0003077_abnormal_cell_cycle | 0.89162018 |
| 104 | MP0003690_abnormal_glial_cell | 0.88957316 |
| 105 | MP0010094_abnormal_chromosome_stability | 0.88940950 |
| 106 | MP0008057_abnormal_DNA_replication | 0.88938188 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.87834622 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.87797906 |
| 109 | MP0005166_decreased_susceptibility_to | 0.87658929 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.87269867 |
| 111 | MP0001663_abnormal_digestive_system | 0.87036061 |
| 112 | MP0009764_decreased_sensitivity_to | 0.86466104 |
| 113 | MP0003279_aneurysm | 0.86081987 |
| 114 | MP0000678_abnormal_parathyroid_gland | 0.85457312 |
| 115 | MP0009697_abnormal_copulation | 0.84126793 |
| 116 | MP0000003_abnormal_adipose_tissue | 0.81932613 |
| 117 | MP0005310_abnormal_salivary_gland | 0.81414716 |
| 118 | MP0008874_decreased_physiological_sensi | 0.78137313 |
| 119 | MP0000598_abnormal_liver_morphology | 0.77713911 |
| 120 | MP0003448_altered_tumor_morphology | 0.77041877 |
| 121 | MP0009763_increased_sensitivity_to | 0.76660732 |
| 122 | MP0010368_abnormal_lymphatic_system | 0.76304698 |
| 123 | MP0000767_abnormal_smooth_muscle | 0.76210212 |
| 124 | MP0004130_abnormal_muscle_cell | 0.75431328 |
| 125 | MP0002254_reproductive_system_inflammat | 0.74658496 |
| 126 | MP0009384_cardiac_valve_regurgitation | 0.73931632 |
| 127 | MP0002970_abnormal_white_adipose | 0.73349169 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.73328209 |
| 129 | MP0005451_abnormal_body_composition | 0.73209209 |
| 130 | MP0010329_abnormal_lipoprotein_level | 0.73153346 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.71554104 |
| 132 | MP0003795_abnormal_bone_structure | 0.71498839 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.71277121 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.71183762 |
| 135 | MP0001533_abnormal_skeleton_physiology | 0.70323502 |
| 136 | MP0003329_amyloid_beta_deposits | 0.70177212 |
| 137 | MP0005334_abnormal_fat_pad | 0.69243666 |
| 138 | MP0009931_abnormal_skin_appearance | 0.68769273 |
| 139 | MP0000249_abnormal_blood_vessel | 0.68270038 |
| 140 | MP0005085_abnormal_gallbladder_physiolo | 0.68189203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 4.93463369 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.72765321 |
| 3 | IgM deficiency (HP:0002850) | 4.68436751 |
| 4 | Recurrent bronchitis (HP:0002837) | 4.49248627 |
| 5 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.23159634 |
| 6 | Chronic otitis media (HP:0000389) | 4.00815781 |
| 7 | Colitis (HP:0002583) | 3.89205052 |
| 8 | Inflammation of the large intestine (HP:0002037) | 3.88248814 |
| 9 | Thrombocytosis (HP:0001894) | 3.84862193 |
| 10 | Gastrointestinal inflammation (HP:0004386) | 3.82642029 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 3.78417786 |
| 12 | Broad face (HP:0000283) | 3.77897643 |
| 13 | Cellulitis (HP:0100658) | 3.74986966 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 3.69644807 |
| 15 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.60400756 |
| 16 | Petechiae (HP:0000967) | 3.59396262 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.58938627 |
| 18 | Abnormal number of erythroid precursors (HP:0012131) | 3.57712453 |
| 19 | Recurrent viral infections (HP:0004429) | 3.51212865 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.45445954 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.42191776 |
| 22 | Thin bony cortex (HP:0002753) | 3.22478602 |
| 23 | Verrucae (HP:0200043) | 3.22400325 |
| 24 | Papilloma (HP:0012740) | 3.22400325 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.21941635 |
| 26 | Recurrent sinusitis (HP:0011108) | 3.21473016 |
| 27 | Lymphopenia (HP:0001888) | 3.20174226 |
| 28 | Increased IgE level (HP:0003212) | 3.12932848 |
| 29 | Aplastic anemia (HP:0001915) | 3.10593110 |
| 30 | Obstructive sleep apnea (HP:0002870) | 3.10251357 |
| 31 | Prolonged bleeding time (HP:0003010) | 3.05499544 |
| 32 | Obstructive lung disease (HP:0006536) | 3.04674950 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04674950 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.99425514 |
| 35 | Cerebral palsy (HP:0100021) | 2.94313706 |
| 36 | Reticulocytopenia (HP:0001896) | 2.90705586 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.89785118 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.89785118 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.89785118 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.89311249 |
| 41 | Meningitis (HP:0001287) | 2.89026759 |
| 42 | Mucopolysacchariduria (HP:0008155) | 2.86224750 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.86224750 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 2.85126894 |
| 45 | J-shaped sella turcica (HP:0002680) | 2.84912415 |
| 46 | B lymphocytopenia (HP:0010976) | 2.84431894 |
| 47 | Abnormality of B cell number (HP:0010975) | 2.84431894 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.80970611 |
| 49 | Abnormality of the fingertips (HP:0001211) | 2.80039541 |
| 50 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78980147 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.78703844 |
| 52 | Orchitis (HP:0100796) | 2.74305191 |
| 53 | Poikiloderma (HP:0001029) | 2.68611054 |
| 54 | Abnormality of T cells (HP:0002843) | 2.68422703 |
| 55 | Chronic sinusitis (HP:0011109) | 2.66410849 |
| 56 | Recurrent abscess formation (HP:0002722) | 2.65826744 |
| 57 | Gingivitis (HP:0000230) | 2.63964657 |
| 58 | Recurrent bacterial skin infections (HP:0005406) | 2.59326727 |
| 59 | Cervical subluxation (HP:0003308) | 2.58913968 |
| 60 | Fatigue (HP:0012378) | 2.56310253 |
| 61 | Joint stiffness (HP:0001387) | 2.54651500 |
| 62 | Neutropenia (HP:0001875) | 2.54614013 |
| 63 | Epistaxis (HP:0000421) | 2.54168262 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.52847259 |
| 65 | Loss of speech (HP:0002371) | 2.45931472 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.44839765 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.42083258 |
| 68 | Hypoplasia of the thymus (HP:0000778) | 2.42077919 |
| 69 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.40489435 |
| 70 | Hyperacusis (HP:0010780) | 2.39444969 |
| 71 | Vacuolated lymphocytes (HP:0001922) | 2.37664746 |
| 72 | Cerebral aneurysm (HP:0004944) | 2.37645073 |
| 73 | Skin rash (HP:0000988) | 2.37536988 |
| 74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.35188435 |
| 75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.35188435 |
| 76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.35188435 |
| 77 | Optic neuritis (HP:0100653) | 2.34836578 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 2.34836578 |
| 79 | Pallor (HP:0000980) | 2.34368636 |
| 80 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.33663500 |
| 81 | Increased serum ferritin (HP:0003281) | 2.32561114 |
| 82 | IgG deficiency (HP:0004315) | 2.31762280 |
| 83 | Malnutrition (HP:0004395) | 2.31349086 |
| 84 | Bronchitis (HP:0012387) | 2.31082413 |
| 85 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.30552354 |
| 86 | Stridor (HP:0010307) | 2.30290624 |
| 87 | Recurrent skin infections (HP:0001581) | 2.29752659 |
| 88 | Nasal polyposis (HP:0100582) | 2.29276736 |
| 89 | Abnormal protein glycosylation (HP:0012346) | 2.29098292 |
| 90 | Abnormal glycosylation (HP:0012345) | 2.29098292 |
| 91 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.29098292 |
| 92 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.29098292 |
| 93 | Type I transferrin isoform profile (HP:0003642) | 2.28036678 |
| 94 | Severe visual impairment (HP:0001141) | 2.27838685 |
| 95 | Hypertensive crisis (HP:0100735) | 2.27047635 |
| 96 | Mitral stenosis (HP:0001718) | 2.25784550 |
| 97 | Impaired platelet aggregation (HP:0003540) | 2.22953928 |
| 98 | Abnormal platelet function (HP:0011869) | 2.22953928 |
| 99 | Emphysema (HP:0002097) | 2.22904277 |
| 100 | Osteomyelitis (HP:0002754) | 2.22023922 |
| 101 | Entropion (HP:0000621) | 2.22001843 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.20993042 |
| 103 | Easy fatigability (HP:0003388) | 2.20936225 |
| 104 | Pancytopenia (HP:0001876) | 2.17854688 |
| 105 | Purpura (HP:0000979) | 2.16160443 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 2.15654150 |
| 107 | Brushfield spots (HP:0001088) | 2.14895153 |
| 108 | Annular pancreas (HP:0001734) | 2.13967046 |
| 109 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.13724328 |
| 110 | Reduced antithrombin III activity (HP:0001976) | 2.13459157 |
| 111 | Lymphoma (HP:0002665) | 2.11680884 |
| 112 | Myositis (HP:0100614) | 2.11668291 |
| 113 | T lymphocytopenia (HP:0005403) | 2.11560151 |
| 114 | Nuclear cataract (HP:0100018) | 2.10585819 |
| 115 | Stomatitis (HP:0010280) | 2.10486669 |
| 116 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.10340490 |
| 117 | Chest pain (HP:0100749) | 2.09487319 |
| 118 | Neonatal hypoglycemia (HP:0001998) | 2.09442369 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 2.09053132 |
| 120 | Spontaneous hematomas (HP:0007420) | 2.05719154 |
| 121 | Pulmonary infiltrates (HP:0002113) | 2.05587568 |
| 122 | Sepsis (HP:0100806) | 2.05037335 |
| 123 | Vasculitis (HP:0002633) | 2.04487571 |
| 124 | Distal lower limb amyotrophy (HP:0008944) | 2.04212357 |
| 125 | Hypertriglyceridemia (HP:0002155) | 2.03478984 |
| 126 | Encephalitis (HP:0002383) | 2.03475892 |
| 127 | Hypochromic anemia (HP:0001931) | 2.00892022 |
| 128 | Abnormality of the thoracic spine (HP:0100711) | 2.00663249 |
| 129 | Restrictive lung disease (HP:0002091) | 2.00652250 |
| 130 | Thoracic kyphosis (HP:0002942) | 2.00425578 |
| 131 | Metaphyseal cupping (HP:0003021) | 2.00297768 |
| 132 | Progressive muscle weakness (HP:0003323) | 1.99374530 |
| 133 | Abnormality of T cell number (HP:0011839) | 1.98771877 |
| 134 | Microretrognathia (HP:0000308) | 1.98461449 |
| 135 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98260641 |
| 136 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98260641 |
| 137 | Polygenic inheritance (HP:0010982) | 1.96496157 |
| 138 | Gingival bleeding (HP:0000225) | 1.95860661 |
| 139 | Hemoptysis (HP:0002105) | 1.95590439 |
| 140 | Hepatosplenomegaly (HP:0001433) | 1.92386294 |
| 141 | Biconcave vertebral bodies (HP:0004586) | 1.91765043 |
| 142 | Hypoproteinemia (HP:0003075) | 1.91619830 |
| 143 | Broad metatarsal (HP:0001783) | 1.91318272 |
| 144 | Neuronal loss in central nervous system (HP:0002529) | 1.91010520 |
| 145 | Urticaria (HP:0001025) | 1.90903353 |
| 146 | Recurrent lower respiratory tract infections (HP:0002783) | 1.90895491 |
| 147 | Abnormality of DNA repair (HP:0003254) | 1.90421294 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 1.89370755 |
| 149 | Autoimmune thrombocytopenia (HP:0001973) | 1.88575430 |
| 150 | Chronic diarrhea (HP:0002028) | 1.85941255 |
| 151 | Pustule (HP:0200039) | 1.85927394 |
| 152 | Macrocytic anemia (HP:0001972) | 1.85814535 |
| 153 | Generalized aminoaciduria (HP:0002909) | 1.85203455 |
| 154 | Hepatitis (HP:0012115) | 1.84285794 |
| 155 | Flat occiput (HP:0005469) | 1.83179502 |
| 156 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82928740 |
| 157 | Premature loss of primary teeth (HP:0006323) | 1.81413476 |
| 158 | Asymmetric septal hypertrophy (HP:0001670) | 1.80868471 |
| 159 | Increased connective tissue (HP:0009025) | 1.79715143 |
| 160 | Hypergammaglobulinemia (HP:0010702) | 1.74203490 |
| 161 | Gastrointestinal dysmotility (HP:0002579) | 1.73640208 |
| 162 | Amyloidosis (HP:0011034) | 1.72797561 |
| 163 | Upper limb amyotrophy (HP:0009129) | 1.72309441 |
| 164 | Distal upper limb amyotrophy (HP:0007149) | 1.72309441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.80869985 |
| 2 | KIT | 3.61219291 |
| 3 | ERN1 | 3.15928120 |
| 4 | PRPF4B | 3.00404926 |
| 5 | PASK | 2.98955292 |
| 6 | RIPK4 | 2.85232458 |
| 7 | CSF1R | 2.72920155 |
| 8 | FLT3 | 2.50757748 |
| 9 | TYK2 | 2.38036799 |
| 10 | MAP3K10 | 2.35359295 |
| 11 | BCKDK | 2.28480489 |
| 12 | BTK | 2.27486156 |
| 13 | SIK2 | 2.21868072 |
| 14 | SMG1 | 2.21072328 |
| 15 | EEF2K | 2.04369029 |
| 16 | LRRK2 | 1.99903037 |
| 17 | GRK6 | 1.88061317 |
| 18 | JAK3 | 1.84992461 |
| 19 | ICK | 1.80605453 |
| 20 | SYK | 1.70102905 |
| 21 | NME2 | 1.68458433 |
| 22 | TRIB3 | 1.61293521 |
| 23 | ZAP70 | 1.57496126 |
| 24 | TGFBR2 | 1.54683131 |
| 25 | PKN2 | 1.54368084 |
| 26 | TEC | 1.51693815 |
| 27 | IRAK3 | 1.48495829 |
| 28 | CLK1 | 1.47978533 |
| 29 | TBK1 | 1.47804048 |
| 30 | IRAK4 | 1.45512945 |
| 31 | EPHB1 | 1.43371224 |
| 32 | TGFBR1 | 1.42133975 |
| 33 | BLK | 1.36707993 |
| 34 | STK16 | 1.35248653 |
| 35 | MAP2K3 | 1.35153076 |
| 36 | IKBKE | 1.26355712 |
| 37 | MAP3K3 | 1.25762855 |
| 38 | CDC42BPA | 1.24946473 |
| 39 | TAOK1 | 1.20752444 |
| 40 | PIM2 | 1.19874323 |
| 41 | MAP2K6 | 1.17874052 |
| 42 | FES | 1.16803735 |
| 43 | TESK2 | 1.16488697 |
| 44 | MAPKAPK3 | 1.15955502 |
| 45 | KDR | 1.15311371 |
| 46 | SIK1 | 1.11441498 |
| 47 | STK10 | 1.10664769 |
| 48 | MAP3K6 | 1.10214381 |
| 49 | TAOK3 | 1.10013723 |
| 50 | WEE1 | 1.08519624 |
| 51 | LYN | 1.08237105 |
| 52 | TAOK2 | 1.05887779 |
| 53 | LCK | 1.04809337 |
| 54 | MAP3K7 | 1.00932847 |
| 55 | MAP3K1 | 1.00823120 |
| 56 | ITK | 0.97769117 |
| 57 | DYRK3 | 0.97074365 |
| 58 | JAK1 | 0.97029881 |
| 59 | DYRK1B | 0.95205890 |
| 60 | PIM1 | 0.95133800 |
| 61 | PDPK1 | 0.94192767 |
| 62 | MAP3K14 | 0.89097979 |
| 63 | RPS6KA2 | 0.88509271 |
| 64 | MAPK11 | 0.88317074 |
| 65 | CDK12 | 0.87133123 |
| 66 | CDK19 | 0.83948339 |
| 67 | HCK | 0.83223133 |
| 68 | MAPK12 | 0.81711652 |
| 69 | MAPK15 | 0.80149910 |
| 70 | TLK1 | 0.79222969 |
| 71 | PDK1 | 0.79175612 |
| 72 | ADRBK2 | 0.78901646 |
| 73 | TNIK | 0.77974731 |
| 74 | FGFR4 | 0.77472177 |
| 75 | IKBKB | 0.77009056 |
| 76 | TNK2 | 0.76968663 |
| 77 | RPS6KB2 | 0.76288811 |
| 78 | TXK | 0.75253984 |
| 79 | CDK4 | 0.74638604 |
| 80 | SIK3 | 0.74283171 |
| 81 | BMX | 0.74015414 |
| 82 | PTK6 | 0.72951408 |
| 83 | MATK | 0.72281632 |
| 84 | MAPK4 | 0.71674521 |
| 85 | FGR | 0.71096497 |
| 86 | PIK3CG | 0.70565607 |
| 87 | IRAK2 | 0.70436287 |
| 88 | NEK2 | 0.67598996 |
| 89 | HIPK2 | 0.65519034 |
| 90 | DAPK1 | 0.65004282 |
| 91 | KSR2 | 0.64590936 |
| 92 | MUSK | 0.63649527 |
| 93 | SCYL2 | 0.63561848 |
| 94 | BRSK2 | 0.61588554 |
| 95 | MAP2K2 | 0.61261393 |
| 96 | PRKD2 | 0.58540528 |
| 97 | MARK3 | 0.58479260 |
| 98 | VRK1 | 0.58161000 |
| 99 | TTN | 0.57848351 |
| 100 | MARK2 | 0.56056035 |
| 101 | PDGFRA | 0.56020472 |
| 102 | TESK1 | 0.55018362 |
| 103 | PRKD3 | 0.54753886 |
| 104 | PRKCH | 0.53844774 |
| 105 | RET | 0.53409373 |
| 106 | MAPKAPK5 | 0.53251978 |
| 107 | FGFR3 | 0.52907279 |
| 108 | ATR | 0.52131529 |
| 109 | CHUK | 0.52048674 |
| 110 | MTOR | 0.51371128 |
| 111 | DDR2 | 0.47651639 |
| 112 | CSK | 0.47172743 |
| 113 | MST1R | 0.46989320 |
| 114 | ILK | 0.46854319 |
| 115 | EPHA2 | 0.45986835 |
| 116 | RPS6KA6 | 0.45959135 |
| 117 | CAMKK1 | 0.44278776 |
| 118 | PAK2 | 0.43861090 |
| 119 | TYRO3 | 0.42440959 |
| 120 | TIE1 | 0.41568423 |
| 121 | MAP3K13 | 0.41417732 |
| 122 | FYN | 0.39222179 |
| 123 | JAK2 | 0.38411524 |
| 124 | PRKD1 | 0.37394846 |
| 125 | MAP3K11 | 0.36987704 |
| 126 | MAPKAPK2 | 0.36383093 |
| 127 | NLK | 0.35900185 |
| 128 | PTK2B | 0.35890759 |
| 129 | PAK4 | 0.34498812 |
| 130 | MAPK7 | 0.34280841 |
| 131 | RIPK1 | 0.34229302 |
| 132 | BRD4 | 0.33910514 |
| 133 | CCNB1 | 0.32983787 |
| 134 | RPS6KL1 | 0.30414280 |
| 135 | RPS6KC1 | 0.30414280 |
| 136 | PRKCQ | 0.28525232 |
| 137 | MAPK3 | 0.27825331 |
| 138 | TSSK6 | 0.26464660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.35466679 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.89413499 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.03171687 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.67156303 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.22606170 |
| 6 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.20281240 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.15453530 |
| 8 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.15203590 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.12274422 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.07755132 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.03811315 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.92365660 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.76729620 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.74452244 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.72908450 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.66461916 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.65685364 |
| 18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.60321372 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.59586048 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57946758 |
| 21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.57746805 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54381863 |
| 23 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48925337 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48892931 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.42654461 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40855109 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.39889572 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.37829846 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32637320 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.32502617 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31803023 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.30390626 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29455238 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28122300 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.26623344 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26534932 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26483909 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.25140353 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24233061 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.23076640 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22938678 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.22196036 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22187430 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.20699812 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18750518 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17612418 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.15683550 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 1.15652069 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.14616447 |
| 50 | Malaria_Homo sapiens_hsa05144 | 1.13623917 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13181745 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12144394 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11095194 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.10115552 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03875013 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03473801 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03460294 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03413286 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01272286 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00696887 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98513603 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98232305 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.97383092 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96683753 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.95009952 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94869979 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94391318 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93741522 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93086412 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91956634 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91592651 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91472556 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.89896614 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88492014 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88139982 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.87436356 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86985571 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85827775 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84985633 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.83988790 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.83014104 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.81297352 |
| 83 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.80536229 |
| 84 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79474496 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.79259556 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.79134236 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78988322 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78959913 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77691299 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77315381 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.76241351 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.76079314 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75531903 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75496538 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75224336 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74950283 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.74502612 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74169466 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73401942 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.72607692 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72422622 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72367688 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72111175 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.71678786 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69431983 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69204699 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69173397 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68537923 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67988617 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67707544 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66803595 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65617455 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.64482469 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.64321464 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62939720 |
| 116 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62717767 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61757730 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.61676892 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60908638 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59820551 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59400334 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59053139 |
| 123 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58523584 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.58229048 |
| 125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58038879 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57946029 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.57812618 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57592451 |
| 129 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56099810 |
| 130 | RNA polymerase_Homo sapiens_hsa03020 | 0.55833896 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55667596 |
| 132 | RNA degradation_Homo sapiens_hsa03018 | 0.55597458 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54452758 |
| 134 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54251324 |
| 135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53768638 |
| 136 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53488745 |
| 137 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53308466 |
| 138 | Hepatitis B_Homo sapiens_hsa05161 | 0.52807318 |
| 139 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52784144 |
| 140 | Tuberculosis_Homo sapiens_hsa05152 | 0.52013152 |
| 141 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51885189 |
| 142 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51045496 |
| 143 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50000584 |
| 144 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49912223 |
| 145 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49908753 |
| 146 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48992868 |
| 147 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48185152 |
| 148 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47806360 |
| 149 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47386732 |
| 150 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47140274 |
| 151 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45681511 |
| 152 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45235326 |
| 153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44873776 |
| 154 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44771114 |
| 155 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44386847 |
| 156 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43742745 |
| 157 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42799445 |
| 158 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40977840 |

